Andrew N Schiff - Net Worth and Insider Trading

Andrew N Schiff Net Worth

The estimated net worth of Andrew N Schiff is at least $91 Million dollars as of 2024-04-25. Andrew N Schiff is the Director of ZELTIQ Aesthetics Inc and owns about 1,610,879 shares of ZELTIQ Aesthetics Inc (ZLTQ) stock worth over $91 Million. Andrew N Schiff is also the Director of Aclaris Therapeutics Inc and owns about 434,455 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $508,312. Details can be seen in Andrew N Schiff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew N Schiff has not made any transactions after 2022-11-14 and currently still holds the listed stock(s).

Transaction Summary of Andrew N Schiff

To

Andrew N Schiff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew N Schiff owns 18 companies in total, including Aclaris Therapeutics Inc (ACRS) , Zosano Pharma Corp (ZSANQ) , and Sunesis Pharmaceuticals Inc (SNSS) among others .

Click here to see the complete history of Andrew N Schiff’s form 4 insider trades.

Insider Ownership Summary of Andrew N Schiff

Ticker Comapny Transaction Date Type of Owner
ACRS Aclaris Therapeutics Inc 2022-11-14 director
ZSANQ Zosano Pharma Corp 2019-04-11 10 percent owner
SNSS Sunesis Pharmaceuticals Inc 2019-07-15 10 percent owner
LOXO Loxo Oncology Inc 2018-07-10 10 percent owner
ZLTQ ZELTIQ Aesthetics Inc 2017-04-28 director & 10 percent owner
SYRS Syros Pharmaceuticals Inc 2016-06-29 10 percent owner
AGRX Agile Therapeutics Inc 2014-05-23 10 percent owner
VRAYQ ViewRay Inc 2016-03-30 10 percent owner
ASXC Asensus Surgical Inc 2013-12-06 director & 10 percent owner
TTOO T2 Biosystems Inc 2015-12-09 10 percent owner
ESPR Esperion Therapeutics Inc 2015-04-23 10 percent owner
CDTX Cidara Therapeutics Inc 2015-04-14 10 percent owner
ARAV Aravive Inc 2015-01-27 10 percent owner
ADMA ADMA Biologics Inc 2012-02-13 10 percent owner
MLNTQ Melinta Therapeutics Inc 2012-02-07 10 percent owner
VIRX Viracta Therapeutics Inc 2019-01-23 10 percent owner
ELEV Elevation Oncology Inc 2021-06-24 other: Managing Member
GLUE Monte Rosa Therapeutics Inc 2021-06-23 director

Andrew N Schiff Latest Holdings Summary

Andrew N Schiff currently owns a total of 2 stocks. Among these stocks, Andrew N Schiff owns 1,610,879 shares of ZELTIQ Aesthetics Inc (ZLTQ) as of August 11, 2016, with a value of $91 Million and a weighting of 99.44%. Andrew N Schiff also owns 434,455 shares of Aclaris Therapeutics Inc (ACRS) as of November 14, 2022, with a value of $508,312 and a weighting of 0.56%.

Latest Holdings of Andrew N Schiff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZLTQ ZELTIQ Aesthetics Inc 2016-08-11 1,610,879 56.48 90,982,446
ACRS Aclaris Therapeutics Inc 2022-11-14 434,455 1.17 508,312

Holding Weightings of Andrew N Schiff


Andrew N Schiff Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew N Schiff has made a total of 0 transactions in ZELTIQ Aesthetics Inc (ZLTQ) over the past 5 years. The most-recent trade in ZELTIQ Aesthetics Inc is the sale of 500,000 shares on August 11, 2016, which brought Andrew N Schiff around $18 Million.

According to the SEC Form 4 filings, Andrew N Schiff has made a total of 6 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Aclaris Therapeutics Inc is the sale of 53,926 shares on November 14, 2022, which brought Andrew N Schiff around $919,438.

Insider Trading History of Andrew N Schiff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew N Schiff Trading Performance

GuruFocus tracks the stock performance after each of Andrew N Schiff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew N Schiff is -20.99%. GuruFocus also compares Andrew N Schiff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew N Schiff within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew N Schiff's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew N Schiff

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.27 -20.99 -44.13 -52.03 -52.45 -20.42
Relative Return to S&P 500(%) -4.24 -25.78 -54.17 -65.73 -65.63 -33.97

Andrew N Schiff Ownership Network

Ownership Network List of Andrew N Schiff

No Data

Ownership Network Relation of Andrew N Schiff


Andrew N Schiff Owned Company Details

What does Aclaris Therapeutics Inc do?

Who are the key executives at Aclaris Therapeutics Inc?

Andrew N Schiff is the director of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .

Aclaris Therapeutics Inc (ACRS) Insider Trades Summary

Over the past 18 months, Andrew N Schiff made 2 insider transaction in Aclaris Therapeutics Inc (ACRS) with a net sale of 95,100. Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net sale of 53,837 shares made by Joseph Monahan , a net sale of 129,240 shares made by Neal Walker , and a net purchase of 12,800 shares made by Douglas J. Manion .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 284,338 shares of Aclaris Therapeutics Inc (ACRS) were sold and 36,995 shares were bought by its insiders, resulting in a net sale of 247,343 shares.

Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aclaris Therapeutics Inc Insider Transactions

No Available Data

Andrew N Schiff Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew N Schiff. You might contact Andrew N Schiff via mailing address: Planet Zanett Inc, 135 E 57th St, New York Ny 10022.

Discussions on Andrew N Schiff

No discussions yet.